Biomimetic coating of bisphosphonate incorporated CDHA on Ti6Al4V

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 2, 2012, Pages 365-374

  Zhou, Huan ^a   Lawrence, Joseph G ^a   Touny, Ahmed H ^b   Bhaduri, Sarit B ^c,d  

^a The University of Toledo   (United States)

^b Helwan University   (Egypt)

^c UNIVERSITY OF TOLEDO   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETIC COATING; BISPHOSPHONATES; BONE TISSUE ENGINEERING; CALCIUM DEFICIENT HYDROXYAPATITE; COPRECIPITATION METHOD; IN-VITRO TESTS; INNER LAYER; OSTEOBLAST CELLS; RELEASE PROFILES; TI ALLOYS; TI-6AL-4V; XRD;

BIOMIMETICS; HYDROXYAPATITE; PROTECTIVE COATINGS; SODIUM; TISSUE ENGINEERING;

LOADING;

ALENDRONIC ACID; BICARBONATE; BIOMIMETIC MATERIAL; CALCIUM CHLORIDE; CARBONATED CALCIUM DEFICIENT HYDROXYAPATITE; MAGNESIUM CHLORIDE; TITANIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOMIMETICS; BODY FLUID; BONE TISSUE; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY; MATERIAL COATING; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TISSUE ENGINEERING; X RAY DIFFRACTION;

ALENDRONATE; CALCIUM; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; DIPHOSPHONATES; DRUG DELIVERY SYSTEMS; DURAPATITE; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; OSTEOPOROSIS; SODIUM; TEMPERATURE; TIME FACTORS; TITANIUM; X-RAY DIFFRACTION;

EID: 84863452052     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4524-z     Document Type: Article

References (39)

1. Narayanan R, Seshadri SK, Kwon TY, Kim KH. Calcium phos-phate-based coatings on titanium and its alloys. J Biomed Mater Res B. 2008;85:279-99.
2. Le Guéhennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater. 2007;23:844-54.
3. Liu Y, De Groot K, Hunziker EB. Osteoinductive implants: the mise-en-scene for drug-bearing biomimetic coatings. Ann Bio-med Eng. 2004;32:398-406.
4. Aves EP, Estevez GF, Sader MS, Sierra JCG, Yurell JCL, Bastos I, Soares G Hydroxyapatite coating by sol-gel on Ti6Al4V alloy as drug carrier. J Mater Sci Mater Med. 2009;20:543-7.
5. Kokubo T. Surface chemistry ofbioactive glass-ceramics. J Non Cryst Solids. 1990;120:138-51.
6. Kokubo T, Miyaji F, Kim HM, Nakamura T. Spontaneous for-mation of bonelike apatite layer on chemically treated titanium metals. J Am Ceram Soc. 1996;79:1127-9.
7. Ma J, Wong H, Kong LB, Peng KW. Biomimetic processings of nanocrystallite bioactive apatite coating on titanium. Nanotech. 2003;14:619-23.
8. Dorozhkin SV, Epple M. Biological and medical significance of calciumphosphates. Angew Chem Int Ed Engl. 2002;41:3130-46.
9. Vallet-Regí M, González-Calbet JM. Calcium phosphates as substitutionofbonetissues. Prog Solid State Chem. 2004; 32: 1-31.
10. Rey C. Calcium phosphate biomaterials and bone mineral. Dif-ferences in composition, structure and properties. Biomaterials. 1990;11:13-5.
11. Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83: 1032-45.
12. Golomb G, Schlossman A, Saadeh H, Levi M, Van Gelder JM, Breuer E. Bisacylphosphonates inhibit hydroxyapatite formation and dissolution in vitro and dystrophic calcification in vivo. Pharm Res. 1992;9:143-8.
13. Russell RG, Rogers MJ. Bisphosphonates from the laboratory to the clinic and back again. Bone. 1999;25:97-106.
14. Elliott SN, Mc Knight W, Davies NM, Mac Naughton WK, Wal-lace JL. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci. 1998;62:77-91.
15. Gonzalez-Moles MA, Bagan-Sebastian JV. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med. 2000;29:514-8.
16. Venesmaa PK, Kröger HP, Miettinen HJ, Jurvelin JS, Suoma-lainen OT, Alhava EM. Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry-a 3-year follow-up study. J Bone Miner Res. 2001;16:1056-61.
17. Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fix-ation in rats. Biomaterials. 2004;25:2133-8.
18. Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Guicheux J, Zambelli PY, Bouler JM, Gauthier O. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone. 2005;36:52-60.
19. Peter B, Gauthier O, Laib S, Bujoli B, Guicheux J, Janvier P, van Lenthe GH, Müller R, Zambelli PY, Bouler JM, Pioletti. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats. J Biomed Mater Res A. 2006;76:133-43.
20. Oliveira AL, Pedro AJ, Arroyo CS, Mano JF, Rodriguez G, Roman JS, Reis RL. Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomate-rials. J Biomed Mater Res B. 2010;92:55-67.
21. Tas AC, Jalota S, Bhaduri SB. Effect of carbonate content and buffer type on calcium phosphonate formation in SBF solutions. J Mater Sci Mater Med. 2006;17:697-707.
22. Tas AC Synthesis of biomimetic Ca-hydroxyapatite powders at 37°C in synthetic body fluids. Biomaterials. 2000;21:1429-38
23. Şamdančoǧlu S, Çalis S, Kir S, Şumnu M. The determination of alendronate sodium in microparticular systems by high perfor-mance liquid chromatography. FABAD J Pharm Sci. 2003;28: 183-92.
24. Jalota S, Bhaduri SB, Tas AC Osteoblast proliferation on neat and apatite-like calcium phosphate-coated titanium foam scaf-folds. Mater Sci Eng C 2007;27:432-40.
25. Kokubo T, Kim HM. Bioactive metals: preparation and proper-ties. J Mater Sci Mater Med. 2004;15:99-107.
26. Meyer JL, Nancollas GH. The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite. Calcif Tissue Res. 1973;13:295-303.
27. Aberg J, Brohede U, Mihranyan A, Strømme M, Engqvist H. Bisphosphonate incorporation in surgical implant coatings by fast loading and co-precipitation at low drug concentrations. J Mater Sci Mater Med. 2009;20:2053-61.
28. Josse S, Faucheux C, Soueidan A, Grimandi G, Massiot D, Alonso B, Janvier P, Laöb S, Gauthier O, Daculsi G, Guicheux J, Bujoli B, Bouler JM. Chemically modified calcium phosphates as novel materials for bisphosphonate delivery. Adv Mater. 2004;16:1423-7.
29. Josse S, Faucheux C, Soueidan A, Grimandi G, Massiot D, Alonso B, Janvier P, Laöb S, Pilet P, Gauthier O, Daculsi G, Guicheux J, Bujoli B, Bouler JM. Novel biomaterials for bis-phosphonate delivery. Biomaterials. 2005;26:2073-80.
30. Leventouri T, Chakoumakos BC, Papanearchou N, Perdiskatsis V. Comparison of crystal structure parameters of natural and synthetic apatites from neutron powder diffraction. J Mater Res. 2001;16:2600-6.
31. Fieisch H, Russell RGG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture in vivo. Science. 1969;165:1262-4
32. Skrtic D, Eanes ED. Effect of 1-hydroxyethylidene-1,1-bis-phosphonate on membrane-mediated calcium phosphate forma-tion in model liposomal suspensions. Bone Miner. 1994;26: 219-29
33. García-Moreno C, Serrano S, Nacher M, Farré M, Díez A, Mariñoso ML, Carbonell J, Mellibovsky L, Nogués X, Ballester J, Aub?́a J. Effect of alendronate on cultured normal human osteoblasts. Bone. 1998;22:233-9.
34. Naidu A, Dechow PC, Spears R, Wright JM, Kessler HP, Opperman LA. The effects of bisphosphonates on osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:829-37.
35. Feng QL, Wang H, Cui FZ, Kim TN. Controlled crystal growth of calcium phosphate on titanium surface by Na OH-treatment. J Cryst Growth. 1999;200:550-7.
36. Lu X, Leng Y. TEM study of calcium phosphate precipitation on bioactive titanium surface. Biomaterials. 2004;25:1779-86.
37. Boanini E, Gazzano M, Rubini K, Bigi A. Composite nanocrys-tals provide new insight on alendronate interaction with hydroxyapatite structure. Adv Mater. 2007;19:2499-502.
38. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. Alendronate-hydroxyapatite nanocomposites and their interac-tion with osteoclasts and osteoblast-like cells. Biomaterials. 2008;29:790-6.
39. Kashii M, Hashimoto J, Nakano T, Umakoshi Y, Yoshikawa H. Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats. J Bone Mineral Meta. 2008;26:24-33.